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Abstract
Single nucleotide substitutions (SNS) are a defining characteristic of cancer genomes. Many SNS
in cancer genomes arise due to errors in DNA replication, which is spatio-temporally stratified.
Here we propose that DNA replication patterns help shape the mutational landscapes of normal
and cancer genomes. Using data on five fully sequenced cancer types and two personal genomes,
we determined that the frequency of intergenic SNS is significantly higher in late DNA replication
timing regions, even after controlling for a number of genomic features. Furthermore, some
substitution signatures are more frequent in certain DNA replication timing zones. Finally,
integrating data on higher-order nuclear organization, we found that genomic regions in close
spatial proximity to late replicating domains display similar mutation spectra as the late replicating
regions themselves. These data suggest that DNA replication timing together with higher-order
genomic organization contribute to the patterns of SNS in normal and cancer genomes.
Introduction
Human cancer genomes exhibit complex mutational landscapes, often characterized by a
large number of single nucleotide substitutions (SNS) found throughout the genome1–3. The
patterns of SNS have been shown to depend on the type of cancer, the number of cell
divisions leading to the initiation and progression of the tumor, as well as tissue-specific
patterns of driver events in cancer4–7. Mutation rates also vary according to different
genomic features such as GC content, recombination rate, CpG islands and others8–10.
Recent advances in genomic profiling methods have enabled the characterization of the
spatial arrangement of genomic material within inter-phase nuclei11, 12. The use of such
databases has enabled an unprecedented mapping of genomic regions not only relative to
each other, but also with regard to different higher-order structures within individual cell
types11, 13, 14. Furthermore, the temporal order of DNA replication in human cells displays
marked variability across genomic regions, in that some areas are replicated early while
others are replicated late during S phase15–17. To date, such data has been used to investigate
evolutionary divergence between species and human nucleotide diversity, showing that late
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replicating regions display larger point mutation rates than early replicating regions18. It was
also recently elucidated that genomic regions of similar replication timing are clustered
spatially in the nucleus, that the two boundaries of somatic copy number alterations
(SCNAs) in cancer genomes tend to be found in regions with the same replication timing,
and that regions replicated early and late display distinct patterns of frequencies of SCNA
boundaries, SCNA size and a preference for deletions over insertions19. For example,
deletions are generally more frequent than amplifications in late as compared to early
replication timing zones.
Recently available genome-wide sequencing data have enabled us to investigate the patterns
of SNS in different temporal phases and spatial compartments during the DNA replication
process. Several studies have illustrated associations between mutation frequencies and
other genetic and epigenetic factors20–22. Woo et al.20 utilized information on selection and
DNA replication timing to study the local variation of mutation frequencies, whereas
Schuster-Bockler et al.20 and the TCGA lung cancer consortium21, 22 proposed a
multivariate analysis approach to investigate epigenetic markers using data from different
cell types.
Here we investigated the patterns of SNS across the genome by using replication timing data
conserved across several cell lines based on data from Hansen et al23, 24 and regions not
under strong selection pressure. We then comprehensively catalogued individual mutation
signatures in these constant late and early replication timing zones. Finally, we utilized
information on higher-order chromatin interactions between genomic material to
demonstrate the coordinative effects between replication timing and nuclear architecture on
the mutational landscape of cancer genomes.
RESULTS
Description of analyzed data sets
We integrated SNS data from completely sequenced genomes of five cancer types
(melanoma25, 26, prostate cancer27, small cell lung cancer28, chronic lymphocytic
leukemia29, and colorectal cancer30; the number of samples analyzed is shown in Table 1),
two completely sequenced personal genomes31, 32, genome-wide DNA replication timing
data23, 24, and data on single nucleotide differences between the human (hg18) and
chimpanzee (panTro2) genomes33. All data was mapped to the human genome version hg18.
Genome-wide replication timing data, obtained using a technique based on massively
parallel sequencing (Repli-Seq) across different human cell types23, was used to classify
genomic regions as ‘constant early’, ‘constant mid’, ‘constant late’ and ‘variable’, according
to the extent of consistency of replication timing regions across the different cell types.
Since cancer development encompasses two intertwined processes – the acquisition of
mutations and natural selection affecting the frequency of the resultant phenotypes3, we first
excluded regions such as the centromere and telomere, Y chromosome, genes and promoters
(±2 kb), repeat elements and ultra-conserved regions33 from the data. The remaining
sequences were expected to evolve nearly neutrally and were termed Filtered Intergenic
Regions (FIRs). Using FIRs only, we were also able to avoid some challenging issues of
variant calling outside of these regions34. The frequency of mutations detected in these
regions was referred to as Adjusted Intergenic Mutation Frequency (AIMF). We mapped
SNS data for each cancer genome onto the FIRs and calculated the AIMF for both the whole
genome and each chromosome individually. Our analysis revealed that the AIMF varies
substantially across the four cancer types (Table 2 and Supplementary Table S1, based on
ANOVA adjusted by multiple comparisons); such variation could be explained by biological
differences in the cancer types and/or differences in the experimental design, sequencing
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technologies and variant calls. Nevertheless, similar trends were observed in the two
completely sequenced personal genomes31, 32, pointing towards meaningful differences
(Table 2). We then also repeated these analyses using genome-wide data instead of FIRs and
obtained consistent results (Table 3).
Mutation frequencies depend on replication timing
We first sought to investigate the effects of DNA replication timing onto the patterns of SNS
frequency in cancer genomes. We utilized only constant late and constant early replication
timing zones23 in order to exclude tissue specificity as a confounding factor. The constant
mid category represented a much smaller part of the human genome and was thus discarded.
We first analyzed the melanoma genomes25. We observed that the mutation frequency in the
FIRs was intimately linked to DNA replication timing: FIRs with constant late replication
timing displayed a significantly higher AIMF compared to those with constant early
replication timing (Mann-Whitney U-Test p-value = 2.075x10−7). This effect was consistent
across all 23 chromosomes (chr1-22 and chrX). We did not identify a significant trend when
investigating the 23 chromosomes individually (Figure 1 and Supplementary Figures S1–
S13). We then repeated our analysis for the other four cancer types (prostate cancer, small
cell lung cancer, chronic lymphocytic leukemia, and colorectal cancer) and two personal
genomes (Watson31 and HuRef32 genomes, analyzed separately) and obtained similar results
(Figure 1). Using a permutation test based on randomly permuting the number of mutations
in the adjusted intergenic regions (Supplementary Figures S14–S15), we recalculated the
permuted AIMFs and compared them to the observed patterns, obtaining a permutation p-
value < 0.001 for all cancer types. To investigate the confounding effects of different
genomic features, we then adjusted for a variety of potential confounders such as gene
density, GC percentage, recombination rate, CpG islands, chromatin states9 and nuclear
lamina-associated regions11 (Supplementary Figures S1–S13 and Table 2). The observed
patterns of SNS with regard to replication timing were consistent in different groups
categorized by these genomic features for all analyzed genomes. This observation suggests
that our findings are unlikely biased by these genomic features and the internal biological
variation among cancer types.
We then repeated our analyses using genome-wide mutation frequencies in constant late and
constant early replication timing regions (Table 3). In general, we obtained robust results.
Surprisingly, in prostate cancer and small cell lung cancer, the genome-wide mutation
frequencies were higher than the AIMF (Table 2 and Table 3); these findings might arise
due to an excess of mutations in repeat elements in these two cancer types, which could be
due to mapping issues, different criteria used for variant calls, or diverse biological
mechanisms of tumorigenesis. After adjusting for several genomic features, we again
obtained results consistent with previous studies showing that genomic regions, which (i)
have a high gene density, (ii) reside in euchromatin regions, or (iii) have a high CpG content
display lower mutation rates. When analyzing adjusted intergenic regions instead of the
whole genome, however, some of these associations were not observed: for instance, we
observed a relatively higher AIMF in melanoma samples as well as the Watson and HuRef
genomes in regions with higher CpG density compared to lower CpG density. One possible
reason for this observation is that SNS in FIRs might not be strongly affected by the active
elements around the regions. Alternatively, this trend might also be due to sequencing or
mapping issues in repeat elements. We also calculated the SNS frequencies in genes only:
the SNS frequency in genes was much lower than the AIMF (chi-squared p-value < 0.0001)
and constant late replication timing regions had larger SNS frequencies in genes
(Supplementary Table S2). To account for the potential inconsistencies of replication timing
across cell lines, we used six alternative replication timing datasets24, 35, 36 from the
Replication Domain database to confirm our findings (Supplementary Figure S16).
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Recent evidence suggests that DNA replication timing may be coordinated across megabase-
scale domains in metazoan genomes, and that early and late replication initiation occurs in
spatio-temporally separate nuclear compartments13, 14,19. Thus, it is possible that DNA
replication timing domains within a larger genomic region (e.g. 1 Mb) might affect the SNS
frequency. For instance, overall, constant late regions could reside in regions that are either
predominantly replicated late or not, and vice versa. To address this issue, we segmented the
human genome into 1 Mb non-overlapping windows and dichotomized these windows into
those with a large versus small proportion of late-replicating domains based on the
prevalence of late replicating base pairs within them. Using different cutoffs to categorize
these 1 Mb windows, we found that in the stratum with a large proportion of late RT
material, the SNS frequencies are higher than in the stratum with a small proportion of late
RT material (Chi-squared p-value < 0.001 in all cases), but the differences of mutation
frequencies between specific early and late replication timing regions hold in both strata
(Supplementary Figure S17). This observation was also consistent across the five cancer
types. Therefore, the prevalence of late replication timing zones on a larger scale is unlikely
to affect our observations. Interestingly, although it has been reported that the transition
regions between late and early replication timing zones are less stable than other parts of the
genome37, we did not observe significant differences in terms of mutation rates between
regions at the center versus at the boundary of individual replication timing zones based on
the constant late and early replication timing data (Supplementary Figure S18).
Different temporal phases of DNA replication have been reported to associate with the
existence of DNA secondary structures38, common fragile sites39 and sometimes cis-
regulatory elements40. To examine whether these factors could confound the different
mutation frequencies in early and late replication timing zones, stratification analyses were
performed based on these factors (Supplementary Figure S19). The preference of SNS in
constant late over constant early DNA replication timing was not masked by these factors,
demonstrating remarkable robustness of our observation in addition to other control
analyses. Besides, we focused on intergenic mutations, whose function is difficult to be
inferred computationally or verified experimentally41. However, some portion of the
intergenic regions can potentially be transcribed42; for instance, noncoding RNAs,
especially large intergenic noncoding RNAs (lincRNAs), may be one missing piece of
unraveling the complexity of the cancer genome41. A recent study has catalogued all known
lincRNAs with the most thorough annotation to date43. Since those adjusted intergenic
mutations included in our study are far away from protein coding genes (median distance to
the closest transcription start site: 400 kb), it is possible that these mutations play a role in
acting on those lincRNAs. We observed that the SNS did not display any global preference
towards residing within FIR regions overlapping with lincRNAs (Supplementary Table S3).
However, since we cannot rule out that mutations varying lincRNAs are more frequent in
cancer genomes and the effects of variation in lincRNAs may be subtle compared with
variation in protein-coding genes, more work is required to delineate these effects.
Mutation signatures depend on replication timing
When investigating the different types of SNS in cancer FIRs, we observed that the patterns
depended on whether FIRs were located in constant early versus constant late replication
timing zones. We considered six types of SNS signatures for each nucleotide in the genome:
A→C: T→G, A→G: T→C, A→T: T→A, C→A: G→T, C→T: G→A, and C→G: G→C.
The proportions of these six types of substitutions were calculated for the constant late and
constant early replication timing FIRs (Figure 2). The overall patterns were significantly
different between constant early and constant late replication timing (Chi-squared test, p-
values < 0.01 in all cases, Figure 2). Similar differences of substitution patterns between
early and late replication timing zones were obtained after controlling for the effects of gene
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density, GC percentage, chromatin state, CpG islands, recombination rate, and nuclear
lamina-associated regions (Supplementary Figures S20–S31). Interestingly, we also
obtained a similar trend using the single nucleotide polymorphism data from the two
completely sequenced personal genomes (Figure 2 and Supplementary Figures S20–S31).
The mutation signatures within genes and promoters were also investigated (Supplementary
Figure S32) to allow a comparison between genic and intergenic regions. We found similar
patterns in genes and FIRs in terms of mutation signatures (Supplementary Figure S32).
Comparing the data across cancer types, we observed some common patterns: some
signatures were more prevalent in the constant late regions, whereas others were
preferentially located in constant early regions. For instance, A→T: T→A transversions
occurred most often in the constant late replication timing regions in all five cancer types.
Out of the five cancer types and the two personal genomes studied, the differences of the
proportion of A→T: T→A in early and late replication timing regions were significant in
prostate cancer samples, melanoma samples from study 2, and Watson and HuRef genomes
(adjusted p-values < 0.01 after multiple testing correction). Overall, the higher proportion of
A→T: T→A in late replication timing zones was observed in 38 out of all the 47 samples
analyzed in our study (Supplementary Figures S33–S40). In contrast, the frequencies of
mutations and the relative proportions of the six types of substitution signatures differed
among the five cancer genomes and two personal genomes; for example, the most frequent
type of substitution in melanoma was the C→T transition25. In general, the consistency in
the relative proportions of substitution signatures in constant early versus constant late
replication timing regions might indicate common mutagenic mechanisms in different
temporal phases of DNA replication.
Mutation frequencies and higher-order nuclear organization
The spatio-temporal segregation of DNA replication timing leads to the formation of DNA
replication factories in which DNA synthesis takes place on multiple strands
simultaneously13, 14. We therefore aimed to test the hypothesis that those regions brought in
close spatial proximity by the proposed fractal organization of the genome12 display similar
mutation frequencies. To address this question, we divided the whole genome into 100 Kb
non-overlapping windows and obtained Hi-C-based long-range interaction data from the
GM06990 and K562 cell lines from Lieberman-Aiden et al12 to measure the spatial
proximity between two individual windows. We excluded any two loci that were closer than
20 Kb from each other on linear DNA. We then stratified all pairs of windows according to
the number of Hi-C reads between them and investigated those windows close to but outside
of the constant late DNA replication timing zones. Those regions that overlapped with FIRs
were referred to as ‘transition to late’ regions; these are the regions that do not reside in
constant late replication timing zones but are linked to constant late region with at least one
Hi-C read. Compared with the AIMF in constant late and constant early DNA replication
timing zones, we found that the AIMF in the ‘transition to late’ regions were much closer to,
yet still smaller than that in constant late DNA replication timing zones. Interestingly, the
AIMF was positively associated with the interaction counts (linear regression p-value < 0.01
for each cancer type, Figure 3). Furthermore, in most cases, the AIMF in these regions was
higher than the genome-wide AIMF (Figure 3). These observations were consistent across
the Hi-C data from the GM06990 and K562 cell lines and the Hi-C data for the GM06990
cell line generated using different restriction enzymes (HindIII and NCoI) (Supplementary
Figures S41–S43).
We also examined whether the different proportions of DNA replication timing (including
constant early, constant mid, constant late, and variable) in the transition zones confounded
our results. To address this issue, we performed the following analysis: the FIRs were
divided into four groups – (i) constant late regions linked with Hi-C reads to constant late
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regions, (ii) constant late regions linked with Hi-C reads to constant early regions, (iii)
constant early regions linked with Hi-C reads to constant late regions, and (iv) constant early
regions linked with Hi-C reads to constant early regions. We found that group (i) had the
highest mutation frequency while group (iv) had the lowest. Moreover, the mutation
frequency of group (ii) was closer to, but still lower than that of group (i), and a similar
trend was observed between groups (iii) and (iv) (Figure 4). Interestingly, all pairwise
comparisons were significantly different (Mann-Whitney U-test, FDR-adjusted p-value <
0.03 in all cases). Taken together, we found that those regions close to late DNA replication
timing zones had similar, though lower, mutation frequencies, suggesting a potential role for
higher-order chromatin organization on the mutagenic mechanisms during DNA replication.
Evolutionary and cancer mutations share genomic locations
We then sought to compare the regions prone to accumulating adjusted intergenic SNS in
cancer genomes versus mutations arising on evolutionary time scales. To this end, we
obtained data on differences between the human hg18 and chimpanzee panTro2 genomes
from the UCSC genome browser33, using a similar approach as in Stamatoyannopoulos et
al18, 44, and compared the number of such changes with the number of SNS in each cancer
type in 1Mb non-overlapping windows. The five cancer types had very different regions that
overlapped with those regions harboring human-chimpanzee SNS (Supplementary Figure
S44). After collapsing the windows with SNS in each of the five cancer types together, we
identified 1,039 such windows with at least one SNS in any of the five cancer types in early
DNA replication timing zones. We then fixed the number of windows with cancer
mutations, and selected the same number of windows with the highest number of human-
chimpanzee SNS. Out of these 1,039 windows, 775 were also present among the human-
chimpanzee SNS windows. We then performed similar analyses in late DNA replication
timing zones, and found that, out of 1,240 windows, 1,208 overlapped in cancer and human-
chimpanzee SNS (Supplementary Figure S45). Although the overlap between regions with
cancer SNS and the regions with the top human-chimpanzee single nucleotide substitutions
varied across different cancer types, after pooling them together, the overlap became larger.
Therefore, we concluded that at the scale of 1Mb, most regions harboring human-
chimpanzee SNS were also regions harboring SNS in any one of the five cancer types. This
finding suggests some common mechanisms between human-chimpanzee evolutionary
transversion and cancer mutagenesis, with no obvious differences in early versus late DNA
replication timing zones.
DISCUSSION
In this paper, we have demonstrated that mutational landscapes of cancer genomes differ
between early and late DNA replication timing zones, with higher mutation frequencies in
late replication timing regions. We identified different patterns of mutation signatures across
these zones; for example, AT|TA mutation signatures commonly appeared in most cancer
samples investigated. This finding implies that some mutagenic and repair mechanisms
might depend on the DNA replication timing of genomic material. The differences in
mutation frequencies and signatures between early and late replication timing also hold after
controlling for several genomic features such as GC percentage, CpG density, recombination
rate, chromatin accessibility, gene density, and lamina-associated domains. Also, the
transition to late regions defined based on Hi-C interactions, although not located in constant
late replication timing regions, have higher mutation frequencies than the overall AIMFs.
Taken together, we conclude that (i) DNA replication timing is a robust genomic feature
affecting SNS frequencies in both cancer and personal genomes, after controlling for many
variables such as GC percentage, gene density, recombination rate, higher-order DNA
replication timing domains, CTCF binding sites, secondary structures and lincRNAs; (ii)
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SNS display specific patterns in early versus late DNA replication timing regions; and (iii)
higher-order nuclear organization, together with DNA replication timing, affects the
mutation frequencies. Furthermore, we found that in general, genome-wide mutation
frequencies were lower than AIMFs. The exceptions in prostate cancer and small cell lung
cancer could be due to an excess of mutations in repeat elements observed in our analysis,
since the majority of the regions excluded from the genome to determine the AIMF were
genes, promoters and repeat elements. The overall higher genome-wide mutation frequency
in late replication timing regions also holds after controlling for several genomic features.
The higher SNS frequencies in late DNA replication timing zones in cancer genomes could
partly arise from the accumulation of single-stranded DNAs, given similar observations in
our analyses and others18 and given that a certain fraction of regions harboring mutations
overlapped between cancer and personal genomes (Supplementary Figure S45). DNA repair
processes can often repair the errors arising during replication45, and it has been suggested
that both DNA replication timing and the efficiency of DNA repair are related to higher-
order chromatin structure45, 46. Our findings suggest that some portions of the genome have
similar mutation frequencies as their counterparts residing closely within the 3D structure of
the nucleus. Chromatin organization and replication timing are intertwined, and could be a
driving force of carcinogenesis by disrupting specific processes such as replication initiation
and replication fork progression46. However, since most mutations analyzed reside in non-
coding parts of the genome, these patterns might only have indirect applicability to an
understanding of the origins of cancer. Our study represents a novel approach to study the
replication process-related SNS in cancer genomes together with the higher-order nuclear
organization. This approach can lead to a better understanding of the mutational landscape
of cancer genomes from the perspective of replication, epigenetics and chromatin structure.
METHODS
Datasets and analyses
Cancer types and sample numbers analyzed are listed in Table 1. All analyses were
performed using human genome version hg18 as reference genome. To obtain the Filtered
Intergenic Regions (FIRs), we employed a similar approach as was used by two other
studies18, 47. We removed all Refseq genes and promoters (up to 2 kb upstream of a gene),
ultra-conserved elements with a conservation score greater than 300, and also intronic
sequences, which are related to transcription-coupled DNA repair. We also excluded repeat
elements, centromeres and telomeres to minimize variant calling complexity in these
regions48, as well as the Y chromosome. All of these data were downloaded from the UCSC
genome browser from the NCBI36/hg18 human genome49. The remaining genomic regions
were termed Filtered Intergenic Regions (FIRs). The total length of FIRs was approximately
780 Mb. We then overlaid the DNA replication timing data obtained from Hansen et al23
onto the FIRs and found that 79.23 Mb and 169.50 Mb of the FIRs resided within replicating
regions that were consistently early or late, respectively, across multiple cell types. The
human GC percentage, CpG island and recombination rate data were also obtained from
UCSC genome browser. Since highly compact heterochromatin stains for Giemsa, whereas
euchromatin is often unstained, we were able to characterize euchromatin and
heterochromatin states globally across different cell types using Giemsa staining data50.
Data on nuclear lamina-associated domains from Guelen et al11 were obtained from the
NCBI GEO database, accession code GSE8854. Genomic regions harboring nuclear lamina-
associated domains are referred to as the nuclear periphery, whereas the remaining regions
are referred to as nuclear core. While analyzing the effects of lamina-associated domains on
the mutation patterns, we used a bootstrap sampling approach (Supplementary Figure S13)
to take into account the variability of nuclear topology across different cell types. The Hi-C
data for GM06990 and K562 cell lines was obtained from Lieberman-Aiden et al12 through
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the GEO database. Moreover, data on genome-wide common fragile sites were obtained
from Durkin and Glover39. The G-quadruplex and CTCF-binding site locations were
obtained from Quadruplex.org51 and CTCFBSDB52, respectively. The large intergenic
noncoding RNA catalog can be obtained from http://www.broadinstitute.org/genome_bio/
human_lincrnas43. All statistical calculations were performed using open source R software.
When necessary, “liftover” software was used to map data from other human genome
versions to hg18.
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Figure 1. Effects of DNA replication timing on mutation rates
The figure shows the Adjusted Intergenic Mutation Frequency (AIMF) for regions residing
within constant early (purple) and constant late DNA replication timing zones (orange) for
completely sequenced genomes of five cancer types and two personal genomes: (A)
melanoma of study 1 (1 sample)25, (B) melanoma of study 2 (25 samples in total)26, (C)
prostate cancer (7 samples in total)27, (D) small cell lung cancer (1 sample)28, (E) chronic
lymphocytic leukemia (4 samples in total)29, (F) colorectal cancer (9 samples in total)30, (G)
Watson31 and (H) HuRef genomes32. The AIMF represents the number of single nucleotide
substitutions observed per base pair in the Filtered Intergenic Regions (FIR), which overlap
with constant early and constant late DNA replication timing zones, respectively. The
horizontal axes display the results for chr1 – chr22 and chrX.
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Figure 2. Relationship between DNA replication timing and substitution patterns
The figure shows the proportions of different types of single nucleotide substitutions in the
constant early (purple) and constant late (orange) DNA replication timing zones for
completely sequenced genomes of five cancer types and two personal genomes: (A)
melanoma of study 125, (B) melanoma of study 226, (C) prostate cancer27, (D) small cell
lung cancer28, (E) chronic lymphocytic leukemia29, (F) colorectal cancer30, (G) Watson31
and (H) HuRef genomes32. The proportions were calculated based on the hg18 reference
allele so that Prob(A→C: T→G) + Prob(A→G: T→C) + Prob(A→T: T→A) = 100%, and
Prob(C→A: G→T) + Prob(C→T: G→A) + Prob(C→G: G→C) = 100% for each of the
constant late and constant early categories. Note that A→T: T→A is a signature commonly
higher in late replication timing in all cancer types. Using the Chi-squared test and
correcting for multiple hypothesis testing by false discovery rate, (B), (C), (G) and (H) are
significantly different with adjusted p-values less than 0.01.
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Figure 3. Higher-order nuclear architecture is associated with mutation frequencies
The figure shows the Adjusted Intergenic Mutation Frequency (AIMF) in the ‘transition-to-
late’ regions defined by different numbers of Hi-C interaction counts from the GM06990
cell line between regions inside and outside the constant late DNA replication timing zones
for (A) the melanoma sample of study 125, (B) melanoma samples of study 226, (C) prostate
cancer samples27, (D) the small cell lung cancer sample28, (E) chronic lymphocytic
leukemia samples29, and (F) colorectal cancer samples30. Statistical significance was
evaluated using simple linear regression, and p-values were obtained. All p-values were less
than 0.01. The green bar shows the genome-wide AIMF, the orange bar the AIMF in
constant late DNA replication timing FIR, and the purple bar the AIMF in constant early
DNA replication timing FIR. The blue dashed line, i.e. the fitted linear model, shows the
positive association between the AIMF and the Hi-C counts that was used to stratify the
regions. Due to the small mutation number in the chronic lymphocytic leukemia genome, we
only used 2–8 Hi-C counts in panel D. The x-axes display the groups of regions stratified by
the number of Hi-C interactions with constant late replication timing regions.
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Figure 4. Effects of transition regions on mutation frequencies
The figure shows the Adjusted Intergenic Mutation Frequency (AIMF) for (A) the
melanoma sample of study 125, (B) melanoma samples of study 226, (C) prostate cancer
samples27, (D) the small cell lung cancer sample28, (E) chronic lymphocytic leukemia
samples29, and (F) colorectal cancer samples30, in four groups of adjusted intergenic
regions: constant late replication timing regions linked with constant late replication timing
regions by Hi-C interactions (purple); constant late replication timing regions linked with
constant early replication timing regions by Hi-C interactions (green); constant early
replication timing regions linked with constant late replication timing regions by Hi-C
interactions (gold); and constant early replication timing regions linked with constant early
replication timing regions by Hi-C interactions (red). The x-axes display the groups of
paired regions stratified by the number of Hi-C reads (2 – 10). All pairwise comparisons
were significantly different from each other (Mann-Whitney U-test, false discovery rate-
adjusted p-values < 0.03 in all cases).
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Table 1
Cancer types and numbers of samples used in this study
The table displays the number of samples and citation for each cancer type analyzed.
Cancer Types Source Number of Samples
Melanoma Study 1 Pleasance et al, Nature 201025 1
Melanoma Study 2 Berger et al, Nature 201226 25
Prostate Cancer Berger et al, Nature 201127 7
Small Cell Lung Cancer Pleasance et al, Nature 201028 1
Chronic Lymphocytic Leukemia Puente et al, Nature 201129 4
Colorectal Cancer Bass et al, Nat Genet. 201130 9
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